Common cold sore virus may reprogram the brain's immune defenses

drug approval expired 100% Health

Researchers at the University of Colorado Anschutz report that herpes simplex virus type 1 can alter how brain immune cells respond to infection. The findings point to a possible link among viral infection, chronic inflammation, and Alzheimer's disease.

๐Ÿ‡บ๐Ÿ‡ธ Location: Aurora — Sources: 18 — First seen: — Last seen:
HSV-1 herpes simplex virus brain immunity neuroinflammation Alzheimer's disease

Linked Entities

University of Colorado Anschutz

organization involved

herpes simplex virus type 1

organization involved

Alzheimer's disease

organization involved

Aurora, Colorado

location involved

Kayem Foods

organization involved

Hong Kong

location involved ๐ŸŒ

United States

location involved ๐ŸŒ

University of Missouri

organization involved

amyotrophic lateral sclerosis

organization involved

GSK

organization involved ๐Ÿ‡บ๐Ÿ‡ธ

Jemperli

organization involved

U.S. Food and Drug Administration

organization involved

Disc Medicine

organization involved

EyePoint, Inc.

organization involved

DURAVYU

organization involved

LUCIA

organization involved

EyePoint

organization involved

Same Day/Next Day (SDND)

organization involved

Atlanta

location involved ๐Ÿ‡บ๐Ÿ‡ธ

Solventum

organization involved

FDA

organization involved ๐Ÿ‡บ๐Ÿ‡ธ

Veradermics, Incorporated

organization involved

VDPHL01

organization involved

Study 304

organization involved

Stoke Therapeutics

organization involved

enGene Therapeutics Inc.

organization involved

Family Farmstead Dairy

organization involved

Maryland

location involved ๐Ÿ‡บ๐Ÿ‡ธ

Pennsylvania

location involved ๐Ÿ‡บ๐Ÿ‡ธ

Alvotech

organization involved

Simlandi

organization involved

The Menopause Society

organization involved

San Diego

location involved ๐Ÿ‡บ๐Ÿ‡ธ

Mounjaro

organization involved ๐Ÿ‡ง๐Ÿ‡ท

Zepbound

organization involved

Rapport Therapeutics

organization involved

RAP-219

organization involved

Arthur G. James Cancer Hospital

organization involved

triple-negative breast cancer

organization involved

Incyte

organization involved

European Society of Medical Oncology

organization involved

ESMO Congress

organization involved

Odyssey Therapeutics, Inc.

organization involved

OD-001

organization involved

UEG Week

organization involved

Zoetis

organization involved

Convenia RTU

organization involved

American Neurological Association

organization involved

Rapport Therapeutics, Inc.

organization involved

Novo Nordisk

organization involved

CagriSema

organization involved

Wegovy

organization involved ๐Ÿ‡บ๐Ÿ‡ธ

Arcus Biosciences, Inc.

organization involved

Casdatifan

organization involved

Kidney cancer

organization involved

Science Daily

organization involved

Alzheimerโ€™s disease

organization involved

Clostridioides difficile

organization involved

Food and Drug Administration

organization involved ๐Ÿ‡ฒ๐Ÿ‡ฝ

Medical Xpress

organization involved

Nicholas Reville

person involved

Semaglutide

organization involved ๐Ÿ‡ฎ๐Ÿ‡ณ

dostarlimab-gxly

organization involved

vTv Therapeutics Inc.

organization involved

Cadisegliatin

organization involved

UC Davis

organization involved

Davis

person involved

REGENXBIO Inc.

organization involved

wet age-related macular degeneration

organization involved

US Food and Drug Administration

organization involved

Hibsago

organization involved

Hepatitis B

organization involved

Roivant

organization involved

non-infectious uveitis

organization involved

Sagimet Biosciences

organization involved

Arcus Biosciences

organization involved

Northwestern Medicine

organization involved

University of Pittsburgh

organization involved

Penn State

organization involved ๐Ÿ‡บ๐Ÿ‡ธ

Mars

location involved

Compass Pathways

organization involved

Spravato

organization involved

psilocybin

organization involved

Parkinson's disease

organization involved

Stanford Medicine

organization involved

Stanford University

organization involved ๐Ÿ‡บ๐Ÿ‡ธ

Texas A&M University

organization involved

pancreatic cancer

organization involved

Roivant Sciences Ltd.

organization involved

brepocitinib

organization involved

Pittsburgh Supercomputing Center

organization involved

Bridges-2

organization involved

American Academy of Ophthalmology

organization involved

New Orleans

location involved ๐Ÿ‡บ๐Ÿ‡ธ

GLP-1 receptor agonists

organization involved

Johns Hopkins Children's Center

organization involved

Cornell University

organization involved

LMNA-related dilated cardiomyopathy

organization involved

CAR T-cell therapy

organization involved

stiff person syndrome

organization involved

Moderna

organization involved

Helus Pharma Inc.

organization involved

type 1 diabetes

organization involved

Merck

organization involved

TriGemX

organization involved

Eli Lilly

organization involved ๐Ÿ‡บ๐Ÿ‡ธ

AstraZeneca

organization involved

Ionis

organization involved

LUCIA Phase III trial

organization involved

Erythropoietic protoporphyria

organization involved

Disc Medicine, Inc.

organization involved

bitopertin

organization involved

APOLLO Phase III trial

organization involved

Lexeo Therapeutics, Inc.

organization involved

PKP2 arrhythmogenic cardiomyopathy

organization involved

Unicycive Therapeutics

organization involved

Fernandinho

person involved

Daniela Carvalho

person involved

OTOF

organization involved

Advocate Aurora Research Institute

organization involved

Advocate Health

organization involved

University of Colorado Boulder

organization involved

STAT

organization involved

American Society of Nephrology

organization involved

Kidney Week 2026

organization involved

Walmart

organization involved ๐Ÿ‡ฎ๐Ÿ‡ณ

University of California San Diego

organization involved

Pittsburgh

location involved ๐Ÿ‡บ๐Ÿ‡ธ

Novo

organization involved

Biohaven

organization involved

Vyglxia

organization involved

Ars Technica

organization involved

Microsoft

organization involved ๐Ÿ‡บ๐Ÿ‡ธ

Mustafa Suleyman

person involved

Science

organization involved

AbbVie

organization involved

lutikizumab

organization involved

STAT News

organization involved

Wall Street

location involved ๐Ÿ‡บ๐Ÿ‡ธ

Keytruda

organization involved

Vera Therapeutics, Inc.

organization involved

ORIGIN Phase III trial

organization involved

Atacicept

organization involved

IMPAACT Network

organization involved

dolutegravir

organization involved

The Lancet HIV

organization involved

MAPK inhibitors

organization involved

Boston Scientific

organization involved

personalized melanoma vaccine

organization involved

Mayo Clinic

organization involved

Alnylam Pharmaceuticals

organization involved

Huntingtonโ€™s disease

organization involved

Bobby Senaha

person involved

Daraxonrasib

organization involved

Tango Therapeutics

organization involved

MSD

organization involved

Hussein Tawbi

person involved

MD Anderson Cancer Center

organization involved

Madrid

location involved ๐Ÿ‡ช๐Ÿ‡ธ

PTSD

organization involved

Tempus AI

organization involved

MacroGenics

organization involved

MGC026

organization involved

melanoma

organization involved

Mayo Clinic Proceedings

organization involved

Dominic King

person involved

Harsha Nori

person involved

Beth Israel Deaconess Medical Center

organization involved

Boston

location involved ๐Ÿ‡บ๐Ÿ‡ธ

Pyxis

organization involved

PYX-106

organization involved

MICVO

organization involved

HNSCC

organization involved

Contributing Articles